Showing results (1-10 of 225) with videos related to
Sort By:
Pageof 23
Journal of the National Comprehensive Cancer Network : JNCCN|May 2, 2009
Selection of patients with hepatocellular carcinoma for sorafenibGhassan K Abou-AlfaGastrointestinal Cancer Research : GCR|April 11, 2009
Treatment of hepatocellular carcinoma: considerations regarding etiology and molecular biologyGhassan K Abou-AlfaSeminars in Oncology|December 21, 2006
Hepatocellular carcinoma: molecular biology and therapyGhassan K Abou-AlfaCurrent Treatment Options in Oncology|January 13, 2019
Systemic Therapy for Advanced Hepatocellular Carcinoma in an Evolving LandscapeKabir Mody, Ghassan K Abou-AlfaClinical Advances in Hematology & Oncology : H&O|July 8, 2014
The role of tyrosine kinase inhibitors in hepatocellular carcinomaSunnie Kim, Ghassan K Abou-AlfaAnnals of Global Health|February 27, 2023
Global Oncology Medical Diplomacy Working Group Inaugural Meeting: Defining Worldwide Barriers to Germline Genomics in Cancer Prevention and ManagementGhassan K Abou-Alfa, Larry Norton, Hepatobiliary Surgery and Nutrition|September 10, 2014
Predicting responsiveness to sorafenib: can the determination of FGF3/FGF4 amplifications enrich for clinical benefit?James J Harding, Ghassan K Abou-AlfaCancer|June 6, 2014
Treating advanced hepatocellular carcinoma: How to get out of first gearJames J Harding, Ghassan K Abou-AlfaClinical and Molecular Hepatology|November 21, 2017
Treatment options after sorafenib failure in patients with hepatocellular carcinomaImane El Dika, Ghassan K Abou-AlfaPageof 23